vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $168.3M, roughly 1.7× PARK NATIONAL CORP). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 25.3%, a 71.0% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 2.2%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 4.9%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
ACAD vs PRK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $168.3M |
| Net Profit | $273.6M | $42.6M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | — |
| Net Margin | 96.3% | 25.3% |
| Revenue YoY | 9.4% | 2.2% |
| Net Profit YoY | 90.3% | 10.4% |
| EPS (diluted) | $1.61 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $168.3M | ||
| Q3 25 | $278.6M | $169.5M | ||
| Q2 25 | $264.6M | $168.7M | ||
| Q1 25 | $244.3M | $157.9M | ||
| Q4 24 | $259.6M | $164.7M | ||
| Q3 24 | $250.4M | $170.3M | ||
| Q2 24 | $242.0M | $157.7M | ||
| Q1 24 | $205.8M | $152.8M |
| Q4 25 | $273.6M | $42.6M | ||
| Q3 25 | $71.8M | $47.2M | ||
| Q2 25 | $26.7M | $48.1M | ||
| Q1 25 | $19.0M | $42.2M | ||
| Q4 24 | $143.7M | $38.6M | ||
| Q3 24 | $32.8M | $38.2M | ||
| Q2 24 | $33.4M | $39.4M | ||
| Q1 24 | $16.6M | $35.2M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 34.3% | ||
| Q2 25 | 12.2% | 35.2% | ||
| Q1 25 | 7.9% | 32.4% | ||
| Q4 24 | 59.1% | — | ||
| Q3 24 | 12.6% | 27.4% | ||
| Q2 24 | 12.6% | 30.6% | ||
| Q1 24 | 7.4% | 27.8% |
| Q4 25 | 96.3% | 25.3% | ||
| Q3 25 | 25.8% | 27.8% | ||
| Q2 25 | 10.1% | 28.5% | ||
| Q1 25 | 7.8% | 26.7% | ||
| Q4 24 | 55.4% | 23.5% | ||
| Q3 24 | 13.1% | 22.4% | ||
| Q2 24 | 13.8% | 25.0% | ||
| Q1 24 | 8.0% | 23.0% |
| Q4 25 | $1.61 | $2.62 | ||
| Q3 25 | $0.42 | $2.92 | ||
| Q2 25 | $0.16 | $2.97 | ||
| Q1 25 | $0.11 | $2.60 | ||
| Q4 24 | $0.86 | $2.38 | ||
| Q3 24 | $0.20 | $2.35 | ||
| Q2 24 | $0.20 | $2.42 | ||
| Q1 24 | $0.10 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $1.4B |
| Total Assets | $1.6B | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $233.5M | ||
| Q3 25 | $258.0M | $218.9M | ||
| Q2 25 | $253.6M | $193.1M | ||
| Q1 25 | $217.7M | $237.6M | ||
| Q4 24 | $319.6M | $160.6M | ||
| Q3 24 | $155.1M | $201.7M | ||
| Q2 24 | $177.1M | $261.5M | ||
| Q1 24 | $204.7M | $306.1M |
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $917.3M | $1.3B | ||
| Q2 25 | $822.4M | $1.3B | ||
| Q1 25 | $765.2M | $1.3B | ||
| Q4 24 | $732.8M | $1.2B | ||
| Q3 24 | $577.2M | $1.2B | ||
| Q2 24 | $516.7M | $1.2B | ||
| Q1 24 | $464.0M | $1.2B |
| Q4 25 | $1.6B | $9.8B | ||
| Q3 25 | $1.3B | $9.9B | ||
| Q2 25 | $1.2B | $9.9B | ||
| Q1 25 | $1.1B | $9.9B | ||
| Q4 24 | $1.2B | $9.8B | ||
| Q3 24 | $976.9M | $9.9B | ||
| Q2 24 | $914.1M | $9.9B | ||
| Q1 24 | $855.1M | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $198.3M |
| Free Cash FlowOCF − Capex | — | $191.9M |
| FCF MarginFCF / Revenue | — | 114.1% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | -0.18× | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $198.3M | ||
| Q3 25 | $74.3M | $52.6M | ||
| Q2 25 | $64.0M | $49.7M | ||
| Q1 25 | $20.3M | $37.9M | ||
| Q4 24 | $40.4M | $178.8M | ||
| Q3 24 | $63.2M | $43.8M | ||
| Q2 24 | $25.0M | $50.9M | ||
| Q1 24 | $29.1M | $35.0M |
| Q4 25 | — | $191.9M | ||
| Q3 25 | $73.9M | $51.1M | ||
| Q2 25 | — | $48.4M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | — | $169.7M | ||
| Q3 24 | $63.2M | $41.7M | ||
| Q2 24 | — | $49.0M | ||
| Q1 24 | — | $31.9M |
| Q4 25 | — | 114.1% | ||
| Q3 25 | 26.5% | 30.1% | ||
| Q2 25 | — | 28.7% | ||
| Q1 25 | — | 23.3% | ||
| Q4 24 | — | 103.0% | ||
| Q3 24 | 25.2% | 24.5% | ||
| Q2 24 | — | 31.1% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | 0.1% | 0.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | -0.18× | 4.65× | ||
| Q3 25 | 1.03× | 1.11× | ||
| Q2 25 | 2.40× | 1.03× | ||
| Q1 25 | 1.07× | 0.90× | ||
| Q4 24 | 0.28× | 4.63× | ||
| Q3 24 | 1.93× | 1.14× | ||
| Q2 24 | 0.75× | 1.29× | ||
| Q1 24 | 1.76× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
PRK
Segment breakdown not available.
